Dare Bioscience (DARE) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts DARE Hot Sheet
Join SI Premium – FREE
Dare Bioscience (NASDAQ: DARE) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
For earnings history and earnings-related data on Dare Bioscience (DARE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
